Skip to main content
GLOBAL PMX logo

GLOBAL PMX — Investor Relations & Filings

Ticker · 4551 ISIN · TW0004551007 TW Manufacturing
Filings indexed 1,963 across all filing types
Latest filing 2020-02-10 Capital/Financing Update
Country TW Taiwan
Listing TW 4551

About GLOBAL PMX

http://www.global.com.tw

Global PMX Co., Ltd. specializes in the manufacturing and processing of high-precision metal components. Utilizing advanced technical capabilities in CNC turning, milling, grinding, and surface treatment, the company produces critical parts for diverse applications. Key products include high-pressure gasoline pumps, diesel nozzle bodies, ABS control valves, and components for fuel injection, transmission, and steering systems. The company also provides precision solutions for medical equipment, semiconductor flow controllers, hard disk drives, and optical electronics. By maintaining strategic partnerships with global Tier 1 suppliers and technology leaders, Global PMX delivers complex components that meet rigorous safety and performance standards. Its operations focus on high-growth markets including medical devices, industrial automation, and advanced transportation systems.

Recent filings

Filing Released Lang Actions
109年1月背書保證與資金貸與
Capital/Financing Update Classification · 90% confidence The document is a financial disclosure from a listed company (智伸科) providing detailed data on fund lending balances and endorsement guarantees for the current and previous months, including limits and cumulative amounts. The content is specific financial data related to capital and guarantees, but it is very short (641 characters) and does not contain comprehensive financial statements or analysis. It appears to be a regulatory disclosure of financing-related information rather than a full financial report. Given the nature of the data (fund lending, guarantees) and the short length, this fits best under Capital/Financing Update (CAP).
2020-02-10 Chinese
109年1月營業收入
Fund Information / Factsheet Classification · 90% confidence The document is a summary report of monthly and cumulative net operating revenue figures for a company named 智伸科 for the period 民國109年01月 (January 2020). It includes numerical data on revenue changes compared to the previous year and explanatory notes about accounting standards (IFRS) and reporting practices. The document is very short (773 characters) and contains no detailed financial statements, management discussion, or comprehensive analysis. It is a brief financial data summary, typical of a financial supplement or factsheet rather than a full report or announcement. There is no indication that this is an announcement of a report publication or a regulatory filing. Therefore, the best fit is Fund Information / Factsheet (FS), which covers brief summaries of key company financials and market info.
2020-02-10 Chinese
109年01月內部人持股異動(事後)
Director's Dealing Classification · 100% confidence The document consists of detailed tables listing shareholdings and changes in share ownership by insiders, including directors, managers, and their related parties. It includes specific data on shares held, increases, decreases, and trust shares. The content is focused on insider shareholding disclosures rather than financial results, management changes, or meeting materials. This type of document aligns with the definition of Director's Dealing (DIRS), which reports personal share transactions by company directors and executives (insider trades). The document is substantive and not merely an announcement or certification, and it does not fit other categories such as Annual Report or Management Reports. Therefore, the appropriate classification is DIRS.
2020-02-06 Chinese
109年01月董事會成員及持股
Director's Dealing Classification · 95% confidence The document is a detailed tabulation of shareholdings and pledged shares of company insiders, including directors, managers, and major shareholders. It lists current holdings, pledged shares, and related party holdings. The content focuses on insider shareholdings and their changes, which aligns with disclosures about personal share transactions or holdings by company directors and executives. There is no indication of financial statements, earnings data, or meeting materials. The document is not a report or announcement of a report but a direct disclosure of insider shareholdings. Therefore, the most appropriate classification is Director's Dealing (DIRS). The document length is 2736 characters, which is consistent with a detailed insider shareholding report rather than a brief announcement or a full financial report.
2020-02-06 Chinese
公告武漢肺炎對本公司及大陸子公司之財務及業務並無重 大影響
Regulatory Filings Classification · 95% confidence The document is a short announcement (817 characters) from a listed company (4551 智伸科) regarding the impact of the Wuhan pneumonia (COVID-19) on the company and its subsidiaries' financial and business operations. It states there is no significant impact and describes preventive measures and operational delays. There is no detailed financial data, no report attached or referenced as being published, and no mention of a formal report type such as Annual Report, Interim Report, or Earnings Release. The document is a regulatory announcement about operational impact and business conditions related to an external event, fitting best under general regulatory announcements. Therefore, it fits the Regulatory Filings (RNS) category as a general compliance and disclosure document without substantive financial statements or report content.
2020-01-31 Chinese
公告本公司股份轉換基準日變更事宜
Regulatory Filings Classification · 95% confidence The document is a short announcement (793 characters) regarding a change in the share conversion base date related to a shareholder meeting decision and regulatory approvals. It does not contain financial statements or detailed financial data. It is an update on a capital structure event but does not announce a new share issue or capital change directly; rather, it informs about a procedural change and pending approvals. Given the nature of the content and the short length, it fits best as a Regulatory Filing (RNS) because it is a general regulatory announcement about corporate actions and approvals without detailed financial or capital issuance data.
2020-01-21 Chinese

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.